Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

675
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
675
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

359
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
359
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

351
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
351
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

519
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
519
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

802
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
802
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploratory study of electroencephalogram markers of responsiveness to surgical noxious stimuli under propofol anaesthesia.

BMC anesthesiology·2026
Same author

A neural mass modelling framework for evaluating EEG source localisation of seizure activity.

Journal of neural engineering·2026
Same author

Tonic-clonic seizures captured during ambulatory video-EEG are frequently unreported.

Epilepsia·2026
Same author

Interictal Epileptiform Discharge Detection Through Probabilistic Diffusion Models with Maximization of Precision Recall Metrics.

International journal of neural systems·2026
Same author

Structural Eigenmodes of the Brain to Improve the Source Localization of EEG: Application to Epileptiform Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

The therapeutic effect of breathing interventions for functional seizures: A scoping review.

Epilepsy & behavior : E&B·2026

Related Experiment Video

Updated: Oct 14, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.6K

Epileptic seizure onset predicts its duration.

Yueyang Liu1, Zhinoos Razavi Hesabi2, Mark Cook2

  • 1Department of Data Science and AI, Faculty of Information Technology, Monash University, Clayton, Victoria, Australia.

European Journal of Neurology
|November 2, 2021
PubMed
Summary

Predicting seizure duration from onset is possible in some epilepsy patients. This breakthrough could enable timely interventions and improve seizure control device efficacy.

Keywords:
dynamic labellinggradient boostingmachine learningseizure duration prediction

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.6K

Related Experiment Videos

Last Updated: Oct 14, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.6K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.6K

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Data Science

Background:

  • Epilepsy is a neurological disorder characterized by recurrent seizures with varied manifestations.
  • Seizure severity and associated risks are often linked to seizure duration.
  • Predicting seizure duration from onset can guide interventions for extended seizures.

Purpose of the Study:

  • To develop and validate a method for predicting seizure duration (long vs. short) based on seizure onset.
  • To create patient-specific classifiers using intracranial electroencephalography (iEEG) data.
  • To assess the feasibility of early seizure duration prediction.

Main Methods:

  • Utilized long-term iEEG recordings from 10 epilepsy patients.
  • Analyzed 2954 seizures to build patient-specific predictive classifiers.
  • Focused on the initial seconds of seizure onset for prediction.

Main Results:

  • Achieved an average Area Under the Receiver Operating Characteristic Curve (AUC) of 0.7.
  • Demonstrated above-chance prediction performance in 5 out of 10 patients.
  • Statistical significance (p-values from 0.04 to 10^-9) confirmed prediction accuracy.

Conclusions:

  • Seizure duration can be predicted from seizure onset in a subset of patients.
  • This predictive capability may aid in forecasting status epilepticus.
  • Findings could inform the optimization of electrical stimulation for seizure control devices.